Reply to Deng et al. and Zhang et al.
- 26 March 2020
- journal article
- letter
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 58 (2), 405-406
- https://doi.org/10.1093/ejcts/ezaa096
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Impact of L4 lymph node dissection on long-term survival in left-side operable non-small-cell lung cancer: a propensity score matching studyEuropean Journal of Cardio-Thoracic Surgery, 2020
- Should the left lower paratracheal lymph node always be dissected in patients with left-sided lung cancer?European Journal of Cardio-Thoracic Surgery, 2020
- L4 lymph node dissection in left-side operable non-small-cell lung cancer: one size fits all?European Journal of Cardio-Thoracic Surgery, 2020
- Lobe-Specific Lymph Node Dissection for Clinical Early-Stage (cIA) Peripheral Non-small Cell Lung Cancer Patients: What and How?Annals of Surgical Oncology, 2020
- The incidence and distribution of mediastinal lymph node metastasis and its impact on survival in patients with non-small-cell lung cancers 3 cm or less: data from 2292 casesEuropean Journal of Cardio-Thoracic Surgery, 2019
- Incidence and Distribution of Lobe-Specific Mediastinal Lymph Node Metastasis in Non-small Cell Lung Cancer: Data from 4511 Resected CasesAnnals of Surgical Oncology, 2018
- A randomized Phase III trial of lobe-specific vs. systematic nodal dissection for clinical Stage I–II non-small cell lung cancer (JCOG1413)Japanese Journal of Clinical Oncology, 2017